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Skeletal and Cardiac Myopathies in Mice
Lacking Utrophin and Dystrophin:
A Model for Duchenne Muscular Dystrophy
R. Mark Grady,* Haibing Teng,³ Mia C. Nichol,² of a line of mice, called mdx, in which a nonsense muta-
tion in the dystrophin gene eliminates expression of theJeanette C. Cunningham,² Robert S. Wilkinson,³
and Joshua R. Sanes² dystrophin polypeptide (Bulfield et al., 1984; Sicinski et
al., 1989). mdx mice show histological signs of muscular*Department of Pediatrics
²Department of Anatomy and Neurobiology dystrophy during their first6 weeks of life, but the subse-
quent course of their disease differs markedly from that³Department of Cell Biology and Physiology
Washington University School of Medicine seen in DMD. The mice show little weakness, have near
normal life spans, and do not develop the severe myo-St. Louis, Missouri 63110
fibrosis and cardiomyopathy characteristic of end-stage
DMD (Carnwath and Shotton, 1987; Torres and Duchen,
1987; Coulton et al., 1988; DiMario et al., 1991). These
Summary differences have limited the utility of mdx mice as mod-
els for investigating the pathogenesis of DMD and test-
Dystrophin is a cytoskeletal protein of muscle fibers; ing potential interventions. Generation of a phenotypi-
its loss in humans leads to Duchenne muscular dystro- cally more accurate model of DMD would therefore be of
phy, an inevitably fatal wasting of skeletal and cardiac considerable practical utility. In addition, understanding
muscle. mdx mice also lack dystrophin, but are only why dystrophin deficiency is less deleterious to mice
mildly dystrophic. Utrophin, a homolog of dystrophin, than to humans could have important therapeutic ramifi-
is confined to the postsynaptic membrane at skeletal cations.
neuromuscular junctions and has been implicated One possible explanation for the difference between
in synaptic development. However, mice lacking utro- mdx mice and DMD patients is that a homologous pro-
phin show only subtle neuromuscular defects. Here, tein compensates for the lack of dystrophin more effec-
we asked whether the mild phenotypes of the two tively in mdx mice than in DMD patients. An excellent
single mutants reflect compensation between the two candidate in this regard is utrophin, which is similar to
proteins. Synaptic development was qualitatively nor- dystrophin in primary sequence and predicted second-
mal in double mutants, but dystrophy was severe and ary structure and associates with the DPC (Blake et al.,
closely resembled that seen in Duchenne. Thus, 1996). Utrophin is confined to the subsynaptic mem-
utrophin attenuates the effects of dystrophin defi- brane at the neuromuscular junction (NMJ) in normal
ciency, and the double mutant may provide a useful skeletal muscle but is readily detectable in extrasynaptic
model for studies of pathogenesis and therapy. portions of regenerating DMD and mdx fibers (Khurana
et al., 1991; Ohlendieck et al., 1991; Pons et al., 1991;
thiMan et al., 1991; Karpati et al., 1993). Moreover, inIntroduction
mdx mice, the muscles with the greatest upregulation
of utrophin exhibit the least pathological changes (Mat-Duchenne muscular dystrophy (DMD) is one of the most
sumura et al., 1992). Recently, Tinsley et al. (1996) dem-common neuromuscular disease in humans. Patients
onstrated that expression of utrophin from a transgenesuffer a progressive wasting of both skeletal and cardiac
can attenuate dystrophic pathology in mdx mice. Thus,muscle that usually leads to death by age twenty (Engel
utrophin can compensate for dystrophin when ex-et al., 1994). DMD results from disruption of the gene that
pressed at high levels; however, whether compensationencodes dystrophin, a 427 kDa protein found throughout
by endogenous utrophin explains the mild phenotypethe cytoplasmic face of the plasma membrane in both
seen in mdx mice remains unclear.skeletal and cardiac muscle cells (Hoffman et al., 1987;
A second focus of interest in utrophin stems from itsAhn and Kunkel, 1993). Dystrophin binds to cytoskeletal
possible involvement in the formation or maintenanceF-actin and to dystroglycan, a transmembrane compo-
of the skeletal NMJ. This idea was suggested by thenent of a multimolecular complex (the dystrophin-asso-
synaptic localization of utrophin and supported by theciated protein complex [DPC]). Dystroglycan, in turn,
finding that agrin, a crucial nerve-derived organizer ofbinds to laminin-2 (merosin) in the overlying basal lam-
postsynaptic differentiation (Gautam et al., 1996), bindsina. Thus, dystrophin is part of a complex that links
specifically to dystroglycan at the NMJ (Bowe et al.,the cytoskeleton to the extracellular matrix (Ervasti and
1994; Campanelli et al., 1994; Gee et al., 1994; SugiyamaCampbell, 1993; Campbell, 1995). In dystrophic muscle,
et al., 1994). These and other results raised the possibil-where this linkage is disrupted, muscle fibers develop
ity that utrophin converted the synaptic DPC into annormally but are easily damaged (Petrof et al., 1993a;
agrin receptor, thereby playing a critical role in synapto-Menke and Jockusch, 1995; Pasternak et al., 1995). The
genesis. To test this hypothesis, we (Grady et al., 1997)damaged fibers degenerate and new fibers, recruited
and Deconinck et al. (1997a) generated utrophin-defi-from satellite cells, regenerate in their place. Regenera-
cient mice. Homozygous mutants (utrn2/2) were viabletion is inefficient, however, so successive rounds of de-
and fertile but displayed a mild congenital myastheniageneration lead to a gradual replacement of muscle by
(defect of the neuromuscular junction), including a 20%±connective tissue (Bell and Conen, 1968; Engel et al.,
30% reduction in the density of acetylcholine receptors1994).
Research on DMD has benefited from the availability (AChRs) in the postsynaptic membrane. The subtlety of
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Figure 1. Poor Growth and Kyphosis in
mdx:utrn2/2 Mice
(a) Double mutants (open squares) are initially
the same size as mdx (closed circles), utrn2/2,
and wild-type (not shown) littermates but
grow more slowly after 3 weeks of age. (b±d)
Radiographs of 6- to 7-week-old mdx:utrn2/2
(b), mdx (c), and wild-type mice (d), showing
small size and pronounced kyphosis in the
double mutant.
this phenotype could be explained if dystrophin com- were also examined. The course of dystrophy in mdx
musclesresembled that described previously (Carnwathpensated for utrophin, a hypothesis analogous to that
invoked to explain the minimal pathology of mdx mice. and Shotton, 1987; Torres and Duchen, 1987; Coulton
et al., 1988). Muscles initially appeared normal (FigureHere, we have analyzed mice deficient in both dys-
trophin and utrophin (mdx:utrn2/2) to determine whether 2a), but necrotic fibers were visible by 3 weeks of age
(data not shown). Degeneration, muscle necrosis, andthe mild phenotypes seen in utrn2/2 or mdx mice are
due to compensation between the two proteins. The infiltration by mononuclear cells peaked at 4 to 5 weeks
of age (Figure 2c). Many fibers had regenerated by thisNMJ develops and functions in the absence of both
utrophin and dystrophin, supporting the idea that the time, as evidenced by their centrally located nuclei (Carl-
son and Faulkner, 1983), and .90% of fibers were regen-DPC is dispensable for synaptogenesis. In contrast,
muscular dystrophy is severe and fatal in the double erated by 10 weeks of age (Figures 2e and 2g). Degener-
ation subsided after z6 weeks, however, and only smallmutants and resembles DMD in many respects. Thus,
utrophin does attenuate the severity of dystrophy in mdx patches of necrosis were seen by 10 weeks (Figure 2e).
Neither degeneration nor regeneration was seen in wild-mice, and mdx:utrn2/2 mice may be a useful model of
DMD. type or utrn2/2 muscles of any age (Figures 2i and 2j).
Degeneration and regeneration were evident in mdx:
utrn2/2 muscle at 2 weeks of age (Figure 2b), a weekResults
earlier than that seen in mdx muscle. Dystrophic pathol-
ogy was similar in mdx and mdx:utrn2/2 mice at 4 to 5Mice deficient in both utrophin and dystrophin (mdx:
utrn2/2) were outwardly similar to wild-type, utrn2/2, and weeks of age (Figures 2c and 2d), but afterward it re-
mained severe in the double mutants while subsidingdyst2/2 (mdx) pups at birth. By 4 weeks of age, however,
the double mutants were significantly smaller than their in mdx mice. By 10 weeks of age, mdx:utrn2/2 muscle
exhibited prominent interstitial fibrosis, while mdx mus-mdx siblings (Figure 1a) and began exhibiting symptoms
of skeletal muscle disease. These included decreased cle had little or none (Figures 2e±2h). Evidence of necro-
sis was prominent along the length of the muscle; neitheractivity, an abnormal waddling gait, and contracted, stiff
limbs. Most striking was a severe curvature of the spine synaptic (central) nor myotendinous (terminal) areas
were selectively affected. Thus, muscle degeneration(kyphosis; Figures 1b±1d), which is a common feature
in DMD, thought to result from asymmetric weakening not only began earlier in mdx:utrn2/2 than in mdx mice
but also persisted at later ages.of the muscles that support the spinal column (Oda et
al., 1993). The severity of all symptoms progressed with The observation that necrosis declines in mdx muscle
once fibers exhibit central nuclei has been interpretedage, and double mutants died between 4 and 14 weeks
of age, with only half living beyond 8 weeks. mdx, utrn2/2, as indicating that mdxmuscle fibers undergo few rounds
of degeneration and regeneration (DiMario et al., 1991;and mdx:utrn1/- mice, in contrast, displayed no outward
pathology and live over one year in our colony. The McGeachie et al., 1993). Likewise, the persistence of
necrosis in mdx:utrn2/2 muscle after nearly all fibers ap-severe neuromuscular abnormalities of the double mu-
tants might reflect defects in the muscle itself (dystro- pear regenerated suggests that multiple rounds of de-
generation and regeneration occur in double mutants.phy) or in the NMJ (myasthenia). We used histological
and physiological methods to distinguish these possibil- Alternatively, however, mdx:utrn2/2 muscle might con-
tain separate populations of stably regenerated fibersities.
and necrotic fibers that fail to regenerate. To distinguish
these alternatives, we selectively stained newly regener-Ongoing Degeneration and Regeneration
in mdx:utrn2/2 Muscle ated fibers with antibodies to embryonic and neonatal
myosin heavy chains. Regenerated muscle fibers ex-We began our histological assessment by comparing
tibialis anterior (hindlimb) muscles from 21 pairs of mdx press these isoforms for only z2 weeks, whereas they
remain centrally nucleated indefinitely (Sartore et al.,and mdx:utrn2/2 littermates ranging in age from 1.5 to
11 weeks. Wild type and utrn2/2 muscles of various ages 1982; DiMario et al., 1991). Regeneration was evident
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by 2 weeks of age in mdx:utrn2/2 muscle and by 3 weeks
in mdx muscle (Figures 3a and 3b). This timing closely
paralleled the onset of necrosis (Figure 2), consistent
with the fact that damaged fibers can regenerate within
3 to 4 days (Mastaglia et al., 1975; Sartore et al., 1982).
Similar numbers of newly regenerated fibers were seen
in mdx and double-mutant muscle at 4 to 5 weeks of
age (Figures 3c and 3d), but significant levels of active
regeneration continued beyond 8 weeks only in double
mutants (Figures 3e±3h). Thus, whereas regeneration
peaks during a brief period in mdx muscle, mdx:utrn2/2
muscle continues to undergo high levels of degeneration
and regeneration.
In addition to the tibialis anterior, we also analyzed the
quadriceps muscle of the thigh, muscles of the forearm,
paraspinal muscles, and diaphragm. Although the timing
and degree of dystrophy varied among muscles, pathol-
ogy was generally similar to that described above (data
Figure 3. Ongoing Regeneration in mdx:utrn2/2 Muscle
Sections from tibialis anterior muscles of 2-week-old (a and b),
4-week-old (c and d), or 10-week-old (e±h) mice were stained with
a monoclonal antibody specific for embryonic and neonatal myosin
heavy chains, which are expressed by newly regenerated muscle
fibers. Regeneration is prominent in both mdx and mdx:utrn2/2 mus-
cle at 4 weeks but begins earlier and persists longer in the latter.
No regeneration is seen in wild-type or utrn2/2 muscle (i and j).
Magnification, 4.83.
not shown). The one exception was the diaphragm,
which is unique in mdx mice in showing ongoing necro-
sis and progressive fibrosis throughout the life of the
animal (Stedman et al., 1991) as well as abnormal me-
chanical properties (Cox et al., 1993). We found that
although degeneration began earlier in mdx:utrn2/2 than
in mdx diaphragm, the pathology became indistinguish-
able in single and double mutants older than 1 month
of age. Thus, compensation by utrophin for the loss of
dystrophin may fail in diaphragm.
The NMJ in mdx:utrn2/2 Mice
To test the possibility that the mild synaptic defectsFigure 2. Degeneration and Regeneration Is Transient in mdx Mus-
observed in utrn2/2 mice (Deconinck et al., 1997a; Gradycle but Persists in mdx:utrn2/2 Muscle
et al., 1997) reflected compensation by dystrophin, weSections from tibialis anterior muscles of 2-week-old (a and b),
analyzed theNMJ in doublemutants. The sizeand shape4-week-old (c and d), or 10-week-old (e±j) mice were stained with
hematoxylin and eosin. Necrosis is prominent in both mdx and of the NMJ were evaluated by staining whole muscles
mdx:utrn2/2 muscle at 4 weeks, and .90% of fibers show central with rhodaminated a-bungarotoxin, which selectively
nuclei characteristic of regeneration (gand h) by 10 weeks. However, binds to AChRs. Control and utrn2/2 synapses were simi-
necrosis begins earlier and persists longer in the double mutants,
lar in appearance, consisting of numerous continuousleading to fibrosis (f). Neither necrosis nor regeneration is seen in
branches arranged in an elliptical plaque (Figures 4awild-type or utrn2/2 muscle at any age (i and j). Magnification: (a)±(f),
(i), and (j), 4.83; (g) and (h), 9.63. and 4b). In mdx and mdx:utrn2/2 muscles, in contrast,
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NMJs bore even fewer folds than either mdx or utrn2/2
synapses (Figures 4e±4g), although the difference be-
tween mdx:utrn2/2 and utrn2/2 was not statistically sig-
nificant (p 5 0.14 by ANOVA). In other ultrastructural
details, mdx:utrn2/2 NMJs appeared normal.
Analysis with labeled bungarotoxin revealed a modest
decrease in the density of AChRs at NMJs in utrn2/2
mice (Deconinck et al., 1997a; Grady et al., 1997). No
difference in the intensity of bungarotoxin staining was
detectable between mdx:utrn2/2 and mdx synapses (Fig-
ures 4c and 4d). A similar conclusion was reached from
intracellular recordings of miniature end plate potentials
(MEPPs). MEPPs result from the activation of AChRs
by spontaneously released quanta of neurotransmitter;
their amplitude is proportional to the density of AChRs
in the postsynaptic membrane. MEPP amplitude did not
differ significantly between mdx (0.43 6 0.02 mV;
mean 6 SE) and mdx:utrn2/2 (0.45 6 0.03 mV) NMJs.
Thus, physiological and histological measures indicated
that the absence of severe synaptic defects in utrn2/2
muscle does not result from compensation by dys-
trophin.
Dystrophin-Associated Proteins
at mdx:utrn2/2 Synapses
Dystrophin and the DPC join the cytoskeleton of muscle
fibers to their extracellular matrix throughout skeletal
muscle. The DPC is also found at the synaptic mem-
brane but in an altered form. The synaptic DPC is linked
to AChRs via the cytoplasmic protein rapsyn (Apel et
al., 1995), and it contains utrophin and b2-syntrophin
along with dystrophin and a1- and b1-syntrophins (Pe-
ters et al., 1994). Furthermore, extrasynaptic laminin-2Figure 4. Subtle Abnormalities at mdx:utrn2/2 Neuromuscular Junc-
(a2/b1/g1) is joined by laminin-11 (a5/b2/g1) and agrintions
in synaptic basal lamina (Sanes, 1995; Patton et al.,(a±d) En face views of endplates in 7- to 8-week-old mice, stained
personalcommunication). The synaptic DPC maintainedwith rhodamine-a-bungarotoxin. mdx andmdx:utrn2/2 endplates are
subdivided into discrete boutons, probably as a consequence of its specialized features in utrn2/2 mice (Grady et al.,
myofiber degeneration and regeneration. (e and f) Electron micros- 1997), leaving open the possibility that some of its com-
copy shows that nerve terminals and Schwann cells are qualitatively ponents might be required for synaptic development,
similar in wild-type (e) and double-mutant (f) muscle, but that the
even though utrophin itself is dispensable. To test thisdensity of junctional folds is reduced in the latter. (g) Quantitation
possibility, we assessed the sarcolemmal distributionof junctional fold density from 66 to 94 measurements per genotype.
of four components of the DPC: b-dystroglycan, a-sar-Magnification: (a)±(d), 20.83; bar in (f) is 1 mm for (e) and (f). Asterisk,
p , 0.01 versus wild type; double asterisk, p , 0.001 versus mdx coglycan, dystrobrevin, and b2-syntrophin. In wild-type
by ANOVA. Bars, SEM. muscle, b2-syntrophin is exclusively synaptic, whereas
the other three proteins are present both synaptically
and extrasynaptically (Figures 5m, 5q, 5u, and data not
shown). Levels of all four proteins were unchanged inNMJs were broken into multiple discrete boutons (Fig-
ures 4c and 4d). This alteration has been reported pre- utrn2/2 muscle but were decreased in mdx muscle (Fig-
ures 5n, 5o, 5r, 5s, 5v, 5w, and data not shown). Forviously in mdx mice and probably results from regenera-
tion rather than from lack of dystrophin per se (Lyons b-dystroglycan and a-sarcoglycan, similar reductions
were seen in mdx:utrn2/2 muscle (Figure 5p and dataand Slater, 1991). Importantly, no qualitative differences
were detectable between mdx and double-mutant syn- not shown). Dystrobrevin and b2-syntrophin, however,
were nearly undetectable in mdx:utrn2/2 muscle (Fig-apses.
Electron microscopy confirmed that double-mutant ures 5t and 5x). Nonetheless, laminin-b2, agrin, and
rapsyn were normal in abundance and localization atsynapses were structurally intact (Figures4e and 4f). The
only structural abnormality noted previously in utrn2/2 mdx:utrn2/2 synapses (Figures 5i±5l and data not
shown). Thus, postsynaptic differentiation can occur notNMJs was a reduction in the number of junctional folds
that invaginate the postsynaptic membrane (Deconinck only in the absence of both utrophin and dystrophin
(Figures 5a±5h) but also despite markedly reducedet al., 1997a; Grady et al., 1997). A similar but less severe
decrease has been reported in mdx synapses (Torres (a-sarcoglycan and dystroglycan) or nearly undetect-
able (dystrobrevin and b2-syntrophin) levels of DPCand Duchen, 1987; Lyons and Slater, 1991). Our analysis
confirmed these results and showed that mdx:utrn2/2 components.
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Figure 5. Disruption of the Dystrophin-Associated Complex at mdx:utrn2/2 Synapses
Sections from tibialis anterior muscles of 4- to 6-week-old mice were doubly stained with the indicated antibodies plus rhodamine-
a-bungarotoxin. Synaptic sites, identified by bungarotoxin staining (not shown), are marked by arrowheads. Utrophin and dystrophin are, as
expected, absent from double mutants (d and h). In addition, the synapse-specific b2-syntrophin is undetectable (x) and levels of b-dystroglycan
(p) and dystrobrevin (t) are markedly reduced. However, rapsyn (l), agrin, and laminin-b2 (not shown) remain concentrated at synaptic sites
in the double mutant. Magnification, 31.23.
Physiological Defects in mdx:utrn2/2 Muscle First, mdx:utrn2/2 sternomastoid muscles were smaller
than those from mdx littermates (mdx, 20.9 6 1.0 mg;To assess the functional consequences of utrophin and
dystrophin deficiencies, we measured the force gener- mdx:utrn2/2, 13.1 6 0.7 mg), consistent with the smaller
size of the double mutants (Figure 1). This difference,ated by the sternomastoid muscle in response to stimu-
lation of its nerve (Figure 6a). Twitch tension following which may reflect smaller and/or fewer fibers, could
account for the weakness observed. Indeed, whena supramaximal stimulus was similar in age-matched
wild-type, mdx, and utrn2/2 muscles. The normal or twitch tension was normalized to the cross-sectional
area of the sternomastoid muscle, the difference be-nearly normal strength of mdx muscle has been noted
previously (Dangain and Vrbova, 1984; Rezvani et al., tween mdx and double mutants was reduced to z25%
(mdx, 6.6 6 0.4 mN; mdx:utrn2/2, 4.9 6 0.4 mN). Thus, size1995; Deconinck et al., 1996). In contrast, mdx:utrn2/2
muscles generated only 40%±60% as much tension as accounts for at least some of the weakness of double-
mutant muscle.those in the other three groups (Figure 6b).
Several factors might explain the relative weakness Different contractile properties of mdx and
mdx:utrn2/2 muscles might also contribute todifferencesof the double-mutant muscles. These include differ-
ences in muscle size, decreased force generating capa- in strength. For example, mdx:utrn2/2 muscles might
also generate less force than mdx muscles because ability per unit size, and defects in neuromuscular trans-
mission. Additional observations allowed us to assess larger fraction of their cross-sectional area is occupied
by necrotic fibers or connective tissue. This is, in fact,these possibilities.
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likely to play some role. Moreover, differences in homolog alone might suffice for apparently normal car-
diac function. Consistent with this hypothesis, large ar-strength could be due to the differences in fiber-type
composition found in dystrophic muscles as myosin eas of necrotic myocytes with infiltrating mononuclear
cells were present in five of nine mdx:utrn2/2 hearts ex-heavy chain isoforms differ in contractile properties (Pe-
trof et al., 1993b). We therefore stained with antibodies amined from 8- to 11-week-old mice (Figure 7d). Necro-
sis was most prominent in the epicardial (outer) surfacethat distinguish fast from slow myosins (see Experimen-
tal Procedures) but found no significant difference in of the right ventricle, but abnormalities were seen
throughout both ventricles. Neither ventricle, however,fiber type composition between mdx and mdx:utrn2/2
muscles (data not shown). Likewise, time to peak twitch seemed significantlydilated orhypertrophic, and degen-
erated myocytes were surrounded by cells that ap-tension, which varies with fiber-type composition (Re-
iser et al., 1988) did not differ detectably between mdx peared normal (Figures 7d and 7g). No significant car-
diac abnormalities were histologically detectable in anyand mdx:utrn2/2 muscles (data not shown). Interestingly,
however, relaxation time (time from peak force to base- of the 12 mdx:utrn2/2 mice ,7 weeks of age or in any
wild-type, mdx, or utrn2/2 mice up to 6 months of ageline) was greatly prolonged in the mdx:utrn2/2 mice com-
pared to the other three groups (Figure 6c). Since relax- (Figures 7a±7c; data not shown).
Necrosis might result from degeneration of myocytesation time is determined in part by the time required to
reduce free calcium levels in the cytoplasm (Close, or from extrinsic (e.g., inflammatory) processes. To
distinguish these alternatives, we sought direct evi-1972), calcium homeostasis may be impaired in double-
mutant muscle. dence for myocyte damage. To this end, ten pairs of
mdx:utrn2/2 and mdxmice were injected with Evans blue,Finally, because the sternomastoid muscle was stimu-
lated via its nerve, some of the weakness in the double a dye that binds to albumin, fluoresces red, and is selec-
tively taken up by cells with leaky plasma membranesmutants could reflect dysfunction of motor axons or
neuromuscular junctions. This possibility was evaluated (Matsuda et al., 1995). Few or no Evans blue-positive
fibers were present in any of the five double mutantsby measuring the decrease in contractile strength fol-
lowing repetitive stimulation. This test resembles the ,7 weeks of age or in any wild-type, utrn2/2, or mdx
hearts (Figure 7e and data not shown). However, of theelectromyographic test used in the diagnosis of myas-
thenia gravis, in which impaired synaptic transmission five injected mdx:utrn2/2 mice .7 weeks of age, the
hearts of three bore substantial areas of abnormallyresults in a progressive decrease in the number of mus-
cle fibers contracting upon prolonged stimulation (En- permeable myocytes (Figure 7f). Interestingly, although
the Evans blue-positive fibers were generally locatedgel, 1994). However, the time for tension to fall to 50%
of maximum was the same for all four genotypes (Figure near areas of active necrosis, they were normal in size
and shape and often free of mononuclear infiltration6e). Likewise, the delay between stimulation and con-
traction (latency), which largely reflects axonal conduc- (Figure 7g). These results demonstrate that the absence
of both utrophin and dystrophin leads to cardiomyopa-tion time, differed negligibly among groups (Figure 6d).
Thus, the weaknessof double-mutant muscle resembles thy and suggest that the damaged fibers eventually die.
that typically seen in dystrophies (primary muscle de-
fects) but not that seen in neuropathies (nerve defects) Discussion
or in myasthenias (synaptic defects).
Muscular dystrophy and cardiomyopathy in mdx mice
are mild compared to that observed in children withCardiomyopathy in mdx:utrn2/2 Hearts
Cardiomyopathy is present in .90% of DMD patients DMD, even though both have mutations that completely
eliminate dystrophin expression. Utrophin, the autoso-(see Discussion) but virtually absent in mdx mice
(Bridges, 1986; Torres and Duchen, 1987; Coulton et al., mal homolog of dystrophin, is upregulated in mdx mice
and DMD patients (Khurana et al., 1991; thiMan et al.,1988). Because dystrophin and utrophin are codistrib-
uted in cardiac myocytes (Grady et al., 1997), either 1991; Matsumura et al., 1992; Karpati et al., 1993). It
Figure 6. Weakness and Contractile Abnor-
mality in mdx:utrn2/2 Muscle
Sternomastoid muscles were attached to a
force transducer and stimulated supramaxi-
mally through their nerve at 0.5 Hz to assess
twitch tension (a±d) or at 100 Hz for 8 s to
assess tetanic tension (e). (a) Representative
tracings of single twitches. (b) Peak tension
is reduced in double-mutant muscle. (c) Re-
laxation time is prolonged in double mutants.
(d) Latency does not vary among genotypes.
(e) Fatigue time, which reflects synaptic fail-
ure, does not vary among genotypes. Bars,
SEM.
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Perhaps most important, the phenotype of the double
mutant resembles DMD more closely than does that of
mdx mice. Shared symptoms include reduced growth,
diminished mobility, limb contractures, weakness,
spinal deformities (kyphosis), cardiomyopathy, myo-
fibrosis, and premature death. In contrast, mdx mice
show little physical impairment, myofibrosis, or cardio-
myopathy and have normal life spans. We do not know
why the double mutants die but suspect that respiratory
failure is at least partially responsible, as is the case
in DMD (Engel et al., 1994); muscle weakness and the
kyphosis that results from it both compromise respira-
tion. Malnutrition and dehydration secondary to dimin-
ished mobility may also be a factor. Finally, as in DMD,
cardiomyopathy could play a role at older ages, but
since it is seen inconsistently, it is unlikely to be the
cause of death for all animals. The similarity of the
mdx:utrn2/2 phenotype to DMD provides new insights
into the pathogenesis of that devastating disease and a
new animal model for testing therapeutic interventions.
Muscular Dystrophy
Utrophin coats the cytoplasmic surface of the entire
sarcolemma in normal embryonic myotubes but be-
comes restricted to synaptic sites as development
proceeds. In dystrophin-deficient mice and humans,
however, utrophin reappears extrasynaptically and as-
sociates with the DPC, particularly in regenerating
fibers, but also in many fibers that do not show patholog-Figure 7. Cardiomyopathy in mdx:utrn2/2 Mice
ical changes (Khurana et al., 1991; Ohlendieck et al.,(a±d) Hematoxylin- and eosin-stained sections of ventricular muscle
1991; thiMan et al., 1991; Matsumura et al., 1992; Karpatifrom 10-week-old mice of the indicated genotypes. Significant ne-
crosis is present only in the double mutant. (e and f) Mice were et al., 1993; Mora et al., 1996). Our main result is that
injected with Evans blue, which binds to albumin and accumulates in this molecular compensation is functionally significant
cells with damaged membranes. Hearts were sectioned and viewed in mice. This finding leads to two further questions: how
with fluorescence optics. Large patches of permeable myocytes
does utrophin attenuate the effects of dystrophin defi-were evident in the double mutant (f), but not in mdx (e), wild-type,
ciency in mice, and why is it less effective in humans?or utrn2/2 (not shown) hearts. (g) Hematoxylin- and eosin-stained
Our results provide two clues to the cellular basis ofsection from the heart of a mouse that had been injected with Evans
blue. Dye-filled (damaged) fibers, which appear purple (arrow), are utrophin's beneficial effects in mice. The first is that
grouped betweenareas of necrosis and areas of normal fibers (pink). muscles in mdx:utrn2/2 mice, like those in children with
Magnification: (a)±(d), 9.63; (e) and (f), 4.83; (g), 19.23. DMD, undergo repeated cycles of necrosis and regener-
ation. In mdx muscle, in contrast, rates of degeneration
and regeneration peak sharply at 4 to 6 weeks, thenmay, therefore, substitute for dystrophin in both mice
and humans but does so more effectively in mice. Like- decline to very low levels thereafter (McGeachie et al.,
1993). This difference is important, because it is thewise, congenital myasthenia is extremely mild in mice
lacking utrophin, despite several lines of evidence that inefficiency and eventual failure of the regenerative pro-
cess that results in replacement of muscle fibers withhad indicated a critical role for this protein in develop-
ment of the neuromuscular junction (Deconinck et al., connective tissue in DMD. This fibrosis, in turn, is re-
sponsible for much of the muscle weakness that ulti-1997a; Grady et al., 1997). By analogy, we speculated
that dystrophin might substitute for utrophin at the syn- mately proves fatal to humans. Thus, stabilization of the
membrane by utrophin may confine degeneration to aapse. Generation of mice lacking both dystrophin and
utrophin allowed us to test these hypotheses. We found limited period in mdx mice, perhaps when growth rate
is high or utrophin levels are at their lowest. Second,that loss of both utrophin and dystrophin leads to a
profound disruption of the entire DPC at the synapse relaxation time following contraction was prolonged
only slightly in mdx muscle but .2-fold in mdx:utrn2/2but permits qualitatively normal synaptic development.
On the other hand, muscular dystrophy and cardiomy- muscle. This parameter reflects, at least in part, the time
required to reduce cytoplasmic calcium concentrationopathy are much more severe in the double mutant than
in either single mutant. Thus, the mild dystrophy seen following contraction. Therefore, impairment of calcium
homeostasis, which has been reported in mdx musclein mdx mice results in part from a beneficial effect of
utrophin, but the mild myasthenia seen in utrn2/2 mice (reviewed in Gillis, 1996), may be more severe in the
double mutant. If this is so, it may be that utrophin limitsdoes not reflect compensation by dystrophin. In the
accompanying paper, Deconinck et al. (1997b [this issue the leakiness of dystrophin-deficient membranes. In
fact, utrophin's roles in regulating cellular integrity andof Cell]) report similar results.
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calcium permeability are likely to be related: elevated mdx:utrn2/2 than of mdx mice. Furthermore, the cardiac
phenotype of the double-mutant mice suggests thatintracellular calcium concentration might either trigger
or result from muscle damage. The double mutant upregulation of endogenous utrophin levels in DMD
hearts would prevent the cardiomyopathy. It is interest-should prove valuable in distinguishing these alterna-
tives. ing to note that utrophin plays a compensatory role in
mdx skeletal muscle, appearing in locations where it isWhy might utrophin fail to compensate effectively for
loss of dystrophin in DMD? One likely factor is that not normally found, whereas utrophin and dystrophin
have overlapping distributions and presumably redun-muscle fiber diameter is larger in humans than in mice.
Because surface-to-volume ratio decreases as fiber dant functions in cardiac tissue.
diameter increases, human sarcolemma experiences
more stress per unit surface area than does murine sar- Congenital Myasthenia
colemma, so dystrophin-deficient human fibers may re- A number of studies had suggested that utrophin and
quire more utrophin to maintain their integrity than their the synaptic DPC might be critical for postsynaptic dif-
murine counterparts. Indeed, in both mice and humans, ferentiation at the neuromuscular junction (discussed in
small fibers are selectively spared (Karpati et al., 1988), Grady et al., 1997). However, targeted mutagenesis of
although this may also reflect their greater upregulation the utrophin gene resulted in mice that had only a mild
of utrophin (Matsumura et al., 1992). If the difference myasthenia, with a 50% reduction in postsynaptic folds
between DMD and mdx is quantitative rather than quali- and a 30% reduction in AChR density (Deconinck et al.,
tative, it becomes important to consider how much extra 1997a; Grady et al., 1997). We therefore suspected that
utrophin an individual with DMD would need to achieve the mild phenotype observed at the utrn2/2 synapse
significant benefit. Recently, Tinsley et al. (1996) showed was due to compensation by dystrophin. However,
that forced expression of high levels of utrophin from a neuromuscular function is qualitatively normal in the
transgene prevents necrosis in mdx mice. Comparable mdx:utrn2/2 mice, even though levels of several DPC
levels would probably be difficult to achieve in humans. components are markedly reduced. We cannot rule out
On the other hand, our results demonstrate that the the possibility that unknown homologs of utrophin, dys-
many-fold lower level of utrophin present in mdx muscle trophin, dystrobrevin, or syntrophin are upregulated at
attenuates dystrophy to a considerable degree. In fact, the double-mutant synapse and provide a compensa-
altering the phenotype of DMD to resemble that in mdx tory mechanism. It is also possible that the low re-
would represent a clinical triumph. We suggest that a maining levels of DPC components are sufficient for
modest increase in utrophin level might suffice for this nearly normal synaptogenesis. However, our results
purpose. suggest that the synaptic dystrophin/utrophin-DPC as-
sembly, like its extrasynaptic counterpart, plays roles in
structural stabilization and maintenance rather than in
Cardiomyopathy development.
Clinically detectable defects in cardiac function are first
apparent in children with DMD at z10 years of age, and Experimental Procedures
nearly all patients have evidence of a cardiomyopathy
by 18 years of age (Nigro et al., 1990). Defects include Animals
Breeding pairs of mdx mice (C57BL/10ScSn) were purchased fromdiminished systolic and diastolic function, impaired
Jackson Laboratories (Bar Harbor, ME). Utrophin-deficient micemyocardial perfusion, and conduction abnormalities.
were generated by targeted mutagenesis (Grady et al., 1997) andHistologically, the atria, ventricles, and conduction sys-
maintained on a C57B5/129J hybrid background. Mice deficient in
tem exhibit degenerative changes, the sarcoplasmic re- both utrophin and dystrophin (mdx:utrn2/2) were generated by cross
ticulum is dilated, myofilaments are disordered, and mi- breeding the single-mutant animals. Genotypes of the mutant mice
tochondrial structure is abnormal (Frankel and Rosser, were determined by polymerase chain reaction using oligonucleo-
tides from the deleted segment of utrophin (Grady et al., 1997) and1976; Wakai et al., 1988; Engel et al., 1994; Quinlivan et
allele-specific oligonucleotides for dystrophin (Amalfitano andal., 1996). Ultimately, cardiac disease may be responsi-
Chamberlain, 1996).ble for 40% of all deaths in DMD (Mukoyama et al.,
1987). Thus, even though completecorrection of skeletal
Histological Analysis
muscle disease in children with DMD would prevent Twenty-one pairs of mdx and mdx:utrn2/2 littermates were used for
death from respiratory failure, most or all patients would light microscopy. Age distribution of the pairs was: 1.5 to 2 weeks
of age, n 5 4 pairs; 3 to 4 weeks, n 5 3; 5 to 7 weeks, n 5 5; 7 tostill die prematurely from heart failure. Lack of significant
9 weeks, n 5 4; 9 to 11 weeks, n 5 5. Wild-type, mdx, and utrn2/2cardiomyopathy is therefore a serious deficiency of the
mice, aged 1 to 26 weeks, were also analyzed. Muscles were frozenmdx mouse as a model for DMD.
in liquid nitrogen-cooled isopentane and sectioned at 7 to 9 mm.Utrophin has the same sarcolemmal distribution as
For bright-field microscopy, sections were stained with hematoxylin
dystrophin in murine cardiac muscle (Grady et al., 1997) and eosin. For immunohistochemistry, sections were incubated for
and is upregulated in mdx heart (Matsumura et al., 1992). 2 to 4 hr with antibody then double stained with fluorescein-conju-
gated second antibody plus rhodamine-a-bungarotoxin (see GradyIt could therefore substitute for dystrophin in mdx heart
et al., 1997, for details). To view NMJs en face, the sternomastoidas it does in mdx skeletal muscle. In fact, this appears
was fixed in 2% paraformaldehyde inPBS, cryoprotected in sucrose,to be the case. In about half the hearts of older mice
frozen, and sectioned longitudinally at 40 mm.lacking both dystrophin and utrophin, we found evi-
Sources of antibodies were as follows: mouse monoclonal anti-
dence of myocyte damage histologically similar to that bodies to utrophin (DRP1, DRP2), dystrophin (DYS1, DYS2), b-dys-
seen in DMD. Thus, as with skeletal muscle, the cardiac troglycan, a-sarcoglycan, and developmental myosin heavy chain
werepurchased from Novocastra Laboratories Ltd. (Newcastle uponpathology of DMD more closely resembles that of
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Tyne, UK). Sources for antibodies to agrin, laminin-b2, rapsyn, and Bell, C.D., and Conen, P.E. (1968). Histopathological changes in
Duchenne muscular dystrophy. J. Neurol. Sci. 7, 529±544.dystrobrevin are given by Grady et al. (1997). Antibodies to adult
myosin heavy chains are described in Donoghue et al. (1991). Anti- Blake, D.J., Tinsley, J.M., and Davies, K.E. (1996). Utrophin: a struc-
bodies to b2-syntrophin (SYN28) were generously provided by S. tural and functional comparison to dystrophin. Brain Pathol. 6,
Froehner (U. of North Carolina; Peters et al., 1994). 37±47.
To detect damaged muscle fibers, Evans blue (10 mg/ml in PBS) Bowe, M.A., Deyst, K.A., Leszyk, J.D., and Fallon, J.R. (1994). Identi-
was injected either intravenously or intraperitoneally (0.1 ml/10 g fication and purification of an agrin receptor from Torpedo postsyn-
body weight) as described by Matsuda et al. (1995). Mice were aptic membranes: a heteromeric complex related to the dystrogly-
sacrificed 12 to 24 hr later and their muscles sectioned as described cans. Neuron 12, 1173±1180.
above and examined under a fluorescence microscope. Evans blue
Bridges, L.R. (1986). The association of cardiac muscle necrosisemits a red fluorescence when activated with green light.
and inflammation with the degenerative and persistent myopathyFor ultrastructural studies, sternomastoid muscles were fixed in
of MDX mice. J. Neurol. Sci. 72, 147±157.4% glutaraldehyde and 4% paraformaldehyde in PBS, washed, re-
Bulfield, G., Siller, W.G., Wight, P.A.L., and Moore, K.J. (1984). Xfixed in 1% OsO4, dehydrated, and embedded in resin. Thin sections
chromosome-linked muscular dystrophy (mdx) in the mouse. Proc.were stained with lead citrate and uranyl acetate. The density of
Natl. Acad. Sci. USA 81, 1189±1192.postsynaptic folds was determined as described in Grady et al.
Campanelli, J.T., Roberds, S.L., Campbell, K.P., and Scheller, R.H.(1997).
(1994). A role for dystrophin-associated glycoproteins and utrophin
in agrin-induced AChR clustering. Cell 77, 663±674.
Electrophysiology
Campbell, K.P. (1995). Molecular basis of three muscular dystro-Contractile properties were measured in six wild-type, five utrn2/2,
phies: disruption of cytoskeleton-extracellular matrix linkage. Cell12 mdx, and seven mdx:utrn2/2 mice. The mdx and mdx:utrn2/2 mice
80, 675±679.were littermates with a mean age of 58 days. The wild-type and
Carlson, B.M. and Faulkner, J.A. (1983). The regeneration of skeletalutrn2/2 mice were of similar age. The entire sternomastoid muscle
muscle fibers following injury: a review. Med. Sci. Sports Exerc. 15,was isolated along with 6 to 7 mm of its nerve. The dissected muscle
187±198.was cleaned of connective tissue and placed in a recording chamber
Carnwath, J.W. and Shotton, D.M. (1987). Muscular dystrophy infilled with Ringer's solution that was continuously bubbled at 258C
the mdx mouse:histopathology of thesoleus andextensor digitorumwith 100% oxygen. One end of the muscle was attached to a fixed
longus muscles. J. Neurol. Sci. 80, 39±54.clamp while the other end was attached to a force transducer via
a small hook. The muscle nerve was attached to a hook-in oil elec- Close, R.I. (1972). Dynamic properties of mammalian skeletal mus-
trode for stimulation (Lichtman and Wilkinson, 1987) and muscle cles. Physiol. Rev. 52, 129±197.
length was adjusted for maximum twitch tension. Single twitches Coulton, G.R., Morgan, J.E., Partridge, T.A., and Sloper, J.C. (1988).
were elicited by supramaximal negative square pulses (2 to 10 V, The mdx mouse skeletal muscle myopathy: I. A histological, mor-
0.3 ms, 0.5 Hz) delivered to the musclenerve; responses to 15 stimuli phometric and biochemical investigation. Neuropathol. Appl. Neuro-
were averaged. Maximal twitch force was normalized for muscle biol. 14, 53±70.
cross sectional area by assuming a 2/3 power proportionality to Cox, G.A., Cole, N.M., Matsumura, K., Phelps, S.F., Hauschka, S.D.,
the muscle mass. To assess fatigability of tension development, Campbell, K.P., Faulkner, J.A., and Chamberlain, J.S. (1993). Over-
muscles were subjected to a 100 Hz stimulus train for 8 s.Fatigability expression of dystrophin in transgenic mdx mice eliminates dystro-
was measured as the time for force to fall to one half its peak value. phic symptoms without toxicity. Nature 364, 725±729.
MEPPs were recorded intracellularly from sternomastoid muscle
Dangain, J., and Vrbova, G. (1984). Muscle development in MDXfibers from an additional three mdx and four mdx:utrn2/2 littermates
mutant mice. Muscle Nerve 7, 700±704.with a mean age of 49 days. Techniques for recording and analyzing
Deconinck, N., Ragot, T., MareÂ chal, G., Perricaudet, M., and Gillis,MEPPs are described by Wilkinson et al. (1992). A total of 58 mdx
M. (1996). Functional protection of dystrophic mouse (mdx) musclesand 35 mdx:utrn2/2 fibers were sampled and 60 to 90 MEPPs were
after adenovirus-mediated transfer of a dystrophin minigene. Proc.measured per fiber. MEPP amplitudes were corrected for differ-
Natl. Acad. Sci. USA 93, 3570±3574.ences in resting potential.
Deconinck, A.E., Potter, A.C., Tinsley, J.M., Wood, S.J., Vater, R.,
Young, C., Metzinger, L., Vincent, A., Slater, C.R., and Davies, K.E.
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